Alzheimer Disease, Mood Disorders, Virtual Reality
Conditions
Brief summary
Presentation & Pre-screening of the control group / reminiscence group Patient/resident pre-screening team meeting for the study Explanation and proposal of the study to patients and their families Signature of resident/patient and family consents Audit of inclusion and non-inclusion criteria Inclusion Medical advice for VR Clinical interview with the family or legal guardian for an accurate life history + an anamnesis interview (psychologist or doctor) with the patient or resident. Creation of video contents Creation of personalized video contents Clinical scales review Evaluation of the number of psychotropic molecules prescribed (coordinating doctor, general practitioner, geriatrician) * Pre-test phase with the patient for the use of the VR headset * Randomisation * Session procedure As previously mentioned, the virtual reality sessions will take place in a quiet setting twice a week in the living or hosting residence. The sessions will be hold over a period of time of 6 weeks. Each subject of the reminiscence group will have two personalised virtual surroundings (after data being collected from team and/or families). The virtual environment will change every 3 weeks in order to avoid the phenomenon of habituation. The subjects of the control group will be exposed to two generic virtual settings (beach, mountain etc.) with a different virtual environment every 3 weeks. During the session, note will be taken on the subject's speech. The session will also be filmed and/or recorded with a prior signed agreement by the patient or his representative. \- Last session (S6) Review of clinical scales (re-testing) Re-evaluation of drug prescriptions
Interventions
PROCEDUREvirtual reality session
The virtual reality sessions will take place in a quiet setting twice a week in the living or hosting residence. The sessions will be hold over a period of time of 6 weeks. The virtual environment will change every 3 weeks in order to avoid the phenomenon of habituation.
Sponsors
Centre Hospitalier Universitaire de Nice
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Intervention model description
The virtual reality sessions will take place twice a week during 6 weeks. Each subject will have two different virtual environment. The virtual environment will change every 3 weeks in order to avoid the phenomenon of habituation.
Eligibility
Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Male or female aged 65 or older * Accompanied in day care or in the geriatric structure of the CHU of Nice (EHPAD-USLD) * Mild to moderate cognitive impairment * Diagnostic criteria for Alzheimer's disease, NINCDS-ADRDA probably, * Positive score on at least one of the following rating scales : * NPI-ES depression/dysphoria and anxiety items + GDS 15 Patients * IA caregiver = 2 on one of 2 dimensions + IA patient = 2 on one of 2 dimensions
Exclusion criteria
* Diagnosed psychiatric pathology * Disabling sensory disorders such as DMLA * Significant hearing loss * Subjects with risk of photosensitive epilepsy or dizziness. Subjects with Lewy body dementia
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Depression and anxiety assessment | change of Hamilton score between inclusion and 6 weeks (before and after therapy) | assessment with Hamilton scale |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| psychotropic drugs consumption | change in psychotropic drugs consumption between inclusion and 6 weeks (before and after therapy) | assessment of psychotropic drugs consumption |
Countries
France
Outcome results
None listed